Fang Ziling相关文献与解析，生知库 | 链接生命科学的每一步

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review

间变性淋巴瘤激酶 (ALK) 抑制剂对伴有 ALK 重排的结直肠癌显示出活性：病例系列和文献综述

Hu, Tingting; Zhan, Jinbo; Li, Li; He, Yan; Lin, Yun; Wang, Jingru; Yu, Haiming; Xiong, Jianping; Fang, Ziling; Deng, Jun; Huang, Shanshan; Xiang, Xiaojun

肿瘤

TRIM47 Facilitates Osteosarcoma Progression via Destabilising FBP1 and Thus Activation of Wnt/Î²-Catenin Pathway.

TRIM47 通过破坏 FBP1 的稳定性，从而激活 Wnt/β-catenin 通路，促进骨肉瘤的进展

期刊:Journal of Cellular and Molecular Medicine

影响因子:4.2

doi:10.1111/jcmm.70753

Wang Heng, Chen Xiao, Nie Fengting, Zhong Min, Fang Zhi, Qiu Zezhi, Zhou Ling, Le Yi, Wei Xianpin, Liao Yanyu, Fang Ziling

[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells

【已撤稿】假叶树皂苷元诱导胰腺癌细胞发生铁死亡

期刊:Oncology Reports

影响因子:3.9

doi:10.3892/or.2025.8863

Song, Zhiwang; Xiang, Xiaojun; Li, Junhe; Deng, Jun; Fang, Ziling; Zhang, Ling; Xiong, Jianping

Pan-cancer analysis of oncogenic role of MAGOH and experiment validation in hepatocellular carcinoma.

MAGOH致癌作用的泛癌分析及肝细胞癌实验验证

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-08678-9

Qiu Zezhi, Le Yi, Liao Yanyu, Chen Xiao, Xin Xing, Nie Fengting, Wei Xianpin, Wang Heng, Fang Ziling

Therapeutic potential of TRIM family proteins in gastric cancer: from signaling pathway regulation to precision targeting strategies

TRIM家族蛋白在胃癌治疗中的应用潜力：从信号通路调控到精准靶向策略

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1628729

Zhao, Caiqing; Qi, Jialing; Zhang, Zhenze; Feng, Qi; Fang, Ziling; Fang, Nian

Random forest-driven mortality prediction in critical IBD care: a dual-database model integrating comorbidity patterns and real-time physiometrics

基于随机森林的IBD危重症患者死亡率预测：整合合并症模式和实时生理指标的双数据库模型

期刊:Frontiers in Medicine

影响因子:3

doi:10.3389/fmed.2025.1624899

Zhang, Zhenze; Zhao, Caiqing; Zhou, Yijun; Yao, Ling; Liu, Peng; Fang, Ziling; Fang, Nian

发表日期：2025

文献求助收藏

Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit

癌突变核糖体蛋白L22 (RPL22/eL22) 通过阻断p53-MDM2通路抑制癌细胞存活。

期刊:Oncotarget

影响因子:

doi:10.18632/oncotarget.21544

Cao, Bo; Fang, Ziling; Liao, Peng; Zhou, Xiang; Xiong, Jianping; Zeng, Shelya; Lu, Hua

Multiple mechanisms and applications of tertiary lymphoid structures and immune checkpoint blockade

三级淋巴结构和免疫检查点阻断的多种机制和应用

Anaplastic Lymphoma Kinase (ALK) Inhibitors Show Activity in Colorectal Cancer With ALK Rearrangements: Case Series and Literature Review

间变性淋巴瘤激酶 (ALK) 抑制剂对伴有 ALK 重排的结直肠癌显示出活性：病例系列和文献综述

TRIM47 Facilitates Osteosarcoma Progression via Destabilising FBP1 and Thus Activation of Wnt/Î²-Catenin Pathway.

TRIM47 通过破坏 FBP1 的稳定性，从而激活 Wnt/β-catenin 通路，促进骨肉瘤的进展

[Retracted] Ruscogenin induces ferroptosis in pancreatic cancer cells

【已撤稿】假叶树皂苷元诱导胰腺癌细胞发生铁死亡

Pan-cancer analysis of oncogenic role of MAGOH and experiment validation in hepatocellular carcinoma.

MAGOH致癌作用的泛癌分析及肝细胞癌实验验证

Therapeutic potential of TRIM family proteins in gastric cancer: from signaling pathway regulation to precision targeting strategies

TRIM家族蛋白在胃癌治疗中的应用潜力：从信号通路调控到精准靶向策略

Random forest-driven mortality prediction in critical IBD care: a dual-database model integrating comorbidity patterns and real-time physiometrics

基于随机森林的IBD危重症患者死亡率预测：整合合并症模式和实时生理指标的双数据库模型

Cancer-mutated ribosome protein L22 (RPL22/eL22) suppresses cancer cell survival by blocking p53-MDM2 circuit

癌突变核糖体蛋白L22 (RPL22/eL22) 通过阻断p53-MDM2通路抑制癌细胞存活。